ARK Genomic Revolution ETF Rating $38.50 +0.22 (+0.57%) As of 09:06 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.55Holdings in ARKG have an aggregate rating of Moderate Buy based on 333 analyst ratings issued in the past year covering 25 companies (93.9% of the portfolio).ARKG Aggregate Price Target$38.28High Prediction$38.28Average Prediction$38.28Low Prediction$38.28Holdings in ARKG have an aggregate price target of $38.28 and a range of $38.28 to $38.28 covering 25 companies (93.9% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.90%TXG10x Genomics$43.22-1.2%1.7611 of 5 stars2.20$32.08 -25.8%157.74%TEMTempus AI$48.41-7.7%3.8626 of 5 stars2.44$68.92 42.4%16News CoverageAnalyst ForecastGap Down7.41%TWSTTwist Bioscience$87.45-6.8%2.1034 of 5 stars2.70$90.30 3.3%10Gap Up6.70%PSNLPersonalis$13.34-13.3%2.1078 of 5 stars2.38$14.25 6.8%8Trending NewsAnalyst DowngradeHigh Trading Volume6.31%CRSPCRISPR Therapeutics$46.99-1.7%3.6073 of 5 stars2.58$67.78 44.2%196.19%ABSIAbsci$8.16-1.7%3.2468 of 5 stars2.78$13.43 64.6%94.41%GHGuardant Health$148.07-5.0%3.419 of 5 stars2.96$160.04 8.1%25Positive News4.39%LLYEli Lilly and Company$1,146.90-2.7%4.5304 of 5 stars2.87$1,283.64 11.9%31Trending NewsAnalyst DowngradeAnalyst Revision4.22%BEAMBeam Therapeutics$26.33-4.4%3.4548 of 5 stars2.64$46.85 77.9%14Positive News4.18%ILMNIllumina$184.68-1.1%3.2758 of 5 stars2.37$156.88 -15.1%19Analyst Downgrade4.01%NTRANatera$262.63-3.2%2.5204 of 5 stars2.82$267.83 2.0%223.01%VCYTVeracyte$57.26-3.2%2.399 of 5 stars2.60$55.88 -2.4%102.94%CDNACareDx$38.37-3.4%2.0462 of 5 stars2.00$33.67 -12.3%62.86%CMPSCompass Pathways$11.67-5.5%3.3562 of 5 stars2.94$24.15 107.0%16Gap Down2.75%RXRXRecursion Pharmaceuticals$2.89-1.7%3.4088 of 5 stars2.20$8.10 180.3%52.36%BFLYButterfly Network$6.70+1.1%0.8789 of 5 stars2.33$5.56 -16.9%62.34%NRIXNurix Therapeutics$22.71-1.8%3.5833 of 5 stars2.79$34.08 50.1%142.33%NTLAIntellia Therapeutics$10.92-4.0%3.3007 of 5 stars2.30$20.19 84.9%232.28%ADPTAdaptive Biotechnologies$21.86-4.6%1.6673 of 5 stars2.57$20.83 -4.7%72.05%SDGRSchrodinger$15.00-2.1%2.481 of 5 stars2.33$20.25 35.0%9News Coverage1.74%WGSGeneDx$60.65-4.5%4.2031 of 5 stars2.56$87.43 44.2%91.67%IONSIonis Pharmaceuticals$52.95-2.6%3.5353 of 5 stars2.77$96.05 81.4%22Analyst Forecast1.47%ALMRAlamar Biosciences$23.92-7.8%2.9724 of 5 stars2.67$30.00 25.4%61.36%CERSCerus$3.15+0.6%3.0336 of 5 stars2.25$4.00 27.0%41.31%PRMEPrime Medicine$3.05-2.6%3.3234 of 5 stars2.88$7.53 146.9%8Positive News This page (BATS:ARKG) was last updated on 7/21/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredOil is settling in yuan now - here's what that means for goldSaudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts